University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84 — San Francisco, California

University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84 is a clinical research site located in San Francisco, California, United States 94110.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84 has participated in 1 clinical trials.

Therapeutic areas: Coronavirus, Covid19.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84?

University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84 conducted?

University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84 has 1 clinical trials on record. Their work covers Coronavirus, Covid19.

Is University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84 accredited by Crixeo Health?

University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California San Francisco (Site 1009), 995 Potrero Ave., Building 80, Ward 84?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.